Condition
Sinus Infection
Total Trials
5
Recruiting
1
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 5 trials
Late-Stage Pipeline
40%
2 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 3 (1)
P 4 (1)
Trial Status
Unknown3
Active Not Recruiting1
Recruiting1
Clinical Trials (5)
Showing 5 of 5 trials
NCT06076304Phase 4RecruitingPrimary
Nasal Steroids, Irrigation, Oral Antibiotics, and Subgroup Targeting for Effective Management of Acute Sinusitis
NCT05454072Not ApplicableActive Not Recruiting
Microbiota Transfer for Chronic Rhinosinusitis
NCT05954273Unknown
Maxillary Sinus Membrane Perforation Incidence During Osseodensification
NCT03729258Phase 3Unknown
Efficacy and Safety of Modified Release Cefpodoxime Formulation in the Treatment of Acute Sinusitis.
NCT05102539UnknownPrimary
Causes of Non-invasive Fungal Sinusitis as Presented in Sohag University Hospital
Showing all 5 trials